deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer

Oct 13, 2008 | NEWS

Latest discoveries add to understanding of individual risk of basal cell carcinoma, and are integrated into the deCODEme™ personal genome analysis scan Reykjavik, ICELAND, October 13, 2008 – Scientists at deCODE genetics (Nasdaq:DCGN) today report the discovery of...

deCODE Launches deCODE BreastCancer™, a Genetic Test to Screen for Risk of the Most Common Forms of Breast Cancer

Oct 8, 2008 | NEWS

Enables women to understand whether they may benefit from more intensive screening, monitoring or preventive drug therapy Reykjavik, ICELAND, October 8, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the launch of deCODE BreastCancer™, a new tool for assessing...

deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer’s and Other Cognitive Disorders

Oct 3, 2008 | NEWS

Reykjavik, ICELAND, October 3, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the filing of an investigational new drug (IND) application for DG071, the company’s novel small-molecule modulator of phosphodiesterase 4 (PDE4), with the US Food and Drug...

deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer

Sep 14, 2008 | NEWS

Detection may be used to complement and target screening for the disease; variants will be integrated into the deCODEme™ personal genome scan. Reykjavik, ICELAND, September 14, 2008 – Scientists at deCODE genetics (Nasdaq:DCGN) and colleagues at Radboud University...

New deCODE Analytical Tool Multiplies Power to Discover Rare Genetic Risk Factors for Common Diseases

Aug 17, 2008 | NEWS

A cost-effective method to enable deCODE to extend its leadership in gene discovery to the next challenge in developing market-leading DNA-based diagnostics August 17, 2008 – deCODE has developed a novel analytical method to increase severalfold the amount of...